Patent No. US 9,090,589 B2: Specific NNOS Inhibitors for the Therapy and Prevention of Human Melanoma

Authors

Richard B. Silverman, Northwestern University
Frank L. Meyskens Jr., University of California, Irvine
Sun Yang, Chapman UniversityFollow
Haitao Ji, Northwestern University
Fengtian Xue
Thomas L. Poulos, University of California, Irvine

Document Type

Patent

Publication Date

7-28-2015

Abstract

Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies.

Recommended Citation

Silverman, Richard B.; Meyskens, Frank L. Jr.; Yang, Sun; Ji, Haitao; Xue, Fengtian; and Poulos, Thomas L., "Patent No. US 9,090,589 B2: Specific NNOS Inhibitors for the Therapy and Prevention of Human Melanoma" (2015). Pharmacy Faculty Articles and Research. 902.
https://digitalcommons.chapman.edu/pharmacy_articles/902